Aminoguanidine, a nitric oxide synthase inhibitor increases the mortality of mice intraperitoneally injected with limiting dosages of virulent Plasmodium berghei NK65

Parasitology International

Volumn 46, Issue 2, 1997, Pages 111-113

  Saito, Susumu ^a   Sendo, Fujiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Mortality; NO; Parasitemia; Plasmodium berghei

Indexed keywords

PLASMODIUM BERGHEI;

EID: 0042733978     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5769(97)00017-2     Document Type: Article

References (14)

1. Mellouk, S., Green, S.J., Nacy, C.A. and Hoffman, S.T. (1991) IFN-g development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146, 3971-3976.
2. Nussler, A.K., Drapier, J.C., Renia, L., Pied, S., Miltge, F., Gentilini, M. et al. (1991) L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin-6 stimulation. Eur. J. Immunol. 21, 227-230.
3. Rockett, K.A., Awburn, M.M., Cowden, W.B. and Clark, I.A. (1991) Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59, 3280-3283.
4. Gyan, B., Troye-Blomberg, M., Perlmann, P. and Bjorkman, A. (1994) Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 16, 371-375.
5. Taylor-Robinson, A.W., Phillips, R.S., Severn, A., Moncada, S. and Liew, F.Y. (1993) The role of TH1 and TH2 cells in rodent malaria infection. Science 260, 1931-1934.
6. Sedegah, M., Finkelman, F. and Hoffman, S.L. (1994) Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. U.S.A. 91, 10700-10702.
7. Stevenson, M.M., Tam, M.F., Wolf, S.F. and Sher, A. (1995) IL-12-induced protection against blood-stage Plasmodium chabaudi as requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155, 2545-2556.
8. Tsuji, M., Miyahira, Y., Nussenzweig, R.S., Aguet, M., Reichel, M. and Zavala, F. (1995) Development of anti-malaria immunity in mice lacking IFN-gamma receptor. J. Immunol. 154, 5338-5344.
9. Jacobs, P., Radzioch, D. and Stevenson, M.M. (1995) Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J. Immunol. 155, 5306-5313.
10. Jacobs, P., Radzioch, D. and Stevenson, M.M. (1996) In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect. Immun. 64, 44-49.
11. Rockett, K.A., Awburn, M.M., Rockett, E.J. and Clark, I.A. (1994) Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am. J. Trop. Med. Hyg. 50, 735-742.
12. Waki, S., Tamura, J., Imanaka, M., Ishikawa, S. and Suzuki, M. (1982) Plasmodium berghei: isolation and maintenance of an irradiation attenuated in the nude mouse. Exp. Parasitol. 53, 335-340.
13. Corbett, J., Titon, R.G., Chang, K.K., Hasan, S., Ido, Y., Wang, J.L. et al. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diavetes 41, 552-556.
14. Beckerman, K.P., Rogers, H.W., Corbert, J.A., Schreiber, R.D., McDaniel, M.L. and Unaue, E.R. (1993) Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immunol. 155, 888-895.